Ginkgo Bioworks opens the fourth biological engineering foundry Date:Oct. 26, 2018 Ginkgo Bioworks announced the opening of Bioworks4, its latest biological engineering foundry. With this fourth foundry, Ginkgo expands its footprint to nearly ... ...
Accept BlogSeptember 24, 2024 Botswana’s Ministry of Health and Ginkgo Launch Pathogen Monitoring Program at Sir Seretse Khama International Airport BlogSeptember 24, 2024 NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture ...
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the launch of a new cell programming project as part of a broader collaboration with Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical
Ginkgo Bioworks MORE ON THIS TOPIC Collaboration Incyte Backs Out of Immuno-Oncology Pact With Agenus February 12, 2025 · 2 min read · Tristan Manalac Infectious disease Anticipating Approval, Gilead Gears Up for Mid-Year Launch for Lenacapavir PrEP...
Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC.
Latest News All news January 23, 2025 Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) January 13, 2025 Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance ...
Embattled Boston-based cell production company Ginkgo Bioworks is curtailing its expansion plans in the city’s Seaport District just a few weeks ahead of its long-planned move into a new building on Fid Kennedy Ave., CEO Jason Kelly told analysts Tuesday evening. The real e...
Get the latest Ginkgo Bioworks Holdings Inc. Class A (DNA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Ginkgo Bioworks Holdings Inc. 27 Drydock Avenue 8th floor Boston, Massachusetts 02210 Phone1 877 422-5362 IndustryN/A SectorN/A Fiscal Year-end12/2024 Revenue$251.46M Net Income-$892.87M 2023 Sales Growth-47.36% Employees1,218 Insider Actions ...
Ginkgo Bioworks Holdings Inc. SEC filings breakout by MarketWatch. View the DNA U.S. Securities and Exchange Commission reporting information.